FORMULATION OF TOPICAL GEL CONTAINING LORNOXICAM
About this article
Received: 03/01/20                Revised: 09/06/20                Published: 11/06/20Abstract
The objectives of this study were to prepare topical gel containing lornoxicam for improved skin penetration of lornoxicam (LNX) for enhancement of its analgesic, anti-inflammation activity and to evaluate the impacts of different penetration enhancers on the in vitro diffusion of lornoxicam. The effect of addition of oleic acid, dimethyl sulfoxid (DMSO), l-menthol on physical properties of the gel and drug permeation was studied. The in-vitro diffusion studies showed a higher and faster release of lornoxicam from the gel containing DMSO than that from the gel containing oleic acid and l-menthol. DMSO exhibited enhanced permeation of lornoxicam from gel formulation. This work shows that lornoxicam can be formulated into Carbopol gel in presence of propylen glycol and polyethylen glycol as solvent, Carbopol as polymer and DMSO may be promising in enhancing permeation.
Keywords
Topical gel; Lornoxicam; Carbopol; Propylen glycol; Skin permeation enhancer.
Full Text:
PDF (Tiếng Việt)References
[1]. N. M. Skjodt, and N. M. Davies, “Clinical pharmacokinetics of lornoxicam A short half-life oxicam,” Clin. Pharmacokinet., vol. 34, no. 6, pp. 421-428, 1998.
[2]. S. Umar et al., “Development and evaluation of transdermal gel of lornoxicam,” Universal Journal of Pharmaceutical Research, vol. 2, no. 1, pp. 17-20, 2017.
[3]. S. A. Al-Suwayeh et al., “Evaluation of Skin Permeation and Analgesic Activity Effects of Carbopol Lornoxicam Topical Gels Containing Penetration Enhancer,” The ScientificWorld Journal, vol. 14, pp. 1-9, 2014.
[4]. S. Y. Ranade, and R. S. Gaud, “Lornoxicam and Frankincense oil transdermal gel: a potential formulation for management of inflammation,” International Journal of Pharmaceutical Sciences and Research, vol. 7, no. 1, pp. 190-198, 2016.Refbacks
- There are currently no refbacks.





